New ANDA Cases

Winter 2016

GENERICally Speaking
Case Name Date Filed Judge Drug Patent No(s).
Mylan Pharms. Inc. v. Shire Labs., Inc., IPR2017-00011 (PTAB) Oct. 4, 2016 N/A Adderall XR® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules) RE41,148
Amgen Inc. v. Ajanta Pharma Ltd., 16-0899 (D. Del.) Oct. 5, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Dr. Reddy’s Labs., Ltd., 16-0900 (D. Del.) Oct. 5, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
UCB, Inc. v. Zydus Pharms. (USA) Inc., 16-0903 (D. Del.) Oct. 6, 2016 Hon. Leonard P. Stark Vimpat® (lacosamide for injection) RE38,551
Astellas Pharma Inc. v. Actavis Elizabeth LLC, 16-0905 (D. Del.) Oct. 6, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 6,346,532, 7,342,117, 7,982,049, 8,835,474, RE44,872
Alcon Research, Ltd. v. Apotex Inc., 16-0906 (D. Del.) Oct. 6, 2016 Hon. Sue L. Robinson Pazeo® (olopatadine hydrochloride ophthalmic solution) 8,791,154
Astellas Pharma Inc. v. Lupin Ltd., 16-0908 (D. Del.) Oct. 7, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Alza Corp. v. Amneal Pharms. of New York, LLC, 16-0914 (D. Del.) Oct. 7, 2016 Hon. Richard G. Andrews Concerta® (methylphenidate hydrochloride tablets) 8,163,798, 9,144,549
Forest Labs., LLC v. Amerigen Pharms., Inc., 16-0917 (D. Del.) Oct. 7, 2016 Hon. Leonard P. Stark Namzaric® (memantine hydrochloride / donepezil hydrochloride extended-release capsules) 8,039,009, 8,058,291, 8,168,209, 8,173,708, 8,283,379, 8,293,794, 8,329,752, 8,338,485, 8,338,486, 8,362,085, 8,580,858, 8,598,233
Alcon Pharms. Ltd. v. Dr. Reddy’s Labs., Inc., 16-6775 (D.N.J.) Oct. 7, 2016 Hon. Peter G. Sheridan Ciprodex® (ciprofloxacin / dexamethasone otic suspension) 9,402,805
Mylan Pharms. Inc. v. Bayer Intellectual Property GmbH, IPR2017-00041 (PTAB) Oct. 7, 2016 N/A Xarelto® (rivaroxaban tablets) 7,157,456
Mylan Pharms. Inc. v. Bayer Intellectual Property GmbH, IPR2017-00042 (PTAB) Oct. 7, 2016 N/A Xarelto® (rivaroxaban tablets) 7,585,860
Mylan Pharms. Inc. v. Bayer Intellectual Property GmbH, IPR2017-00043 (PTAB) Oct. 7, 2016 N/A Xarelto® (rivaroxaban tablets) 7,592,339
Astellas Pharma Inc. v. Zydus Pharms. (USA), Inc., 16-0924 (D. Del.) Oct. 11, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Amgen Inc. v. Amneal Pharms. LLC, 16-0925 (D. Del.) Oct. 11, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Apotex Inc., 16-0926 (D. Del.) Oct. 11, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Breckenridge Pharm. Inc., 16-0927 (D. Del.) Oct. 11, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Hetero USA Inc., 16-0928 (D. Del.) Oct. 11, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Astellas Pharma Inc. v. Windlas Healthcare, Pvt. Ltd., 16-0930 (D. Del.) Oct. 12, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Astellas Pharma Inc. v. Aurobindo Pharma Ltd., 16-0942 (D. Del.) Oct. 13, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Astellas Pharma Inc. v. Prinston Pharm. Inc., 16-0943 (D. Del.) Oct. 13, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Mallinckrodt Hospital Products IP Ltd. v. Praxair Distribution, Inc., 16-0944 (D. Del.) Oct. 13, 2016 Hon. Gregory M. Sleet Inomax® (nitric oxide for inhalation) 9,408,993
Astellas Pharma Inc. v. Sandoz Inc., 16-0952 (D. Del.) Oct. 14, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
AstraZeneca AB v. Glenmark Pharms. Ltd., 16-7330 (D.N.J.) Oct. 14, 2016 Hon. Mary L. Cooper Nexium® 24HR (esomeprazole magnesium delayed-release capsules) 6,369,085, 7,411,070, 8,466,175
Otsuka Pharm. Co., Ltd. v. Stason Indus. Corp., 16-7346 (D.N.J.) Oct. 14, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302
Astellas Pharma Inc. v. Sawai Pharm. Co., Ltd., 16-0954 (D. Del.) Oct. 17, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 6,346,532, 7,342,117, 7,982,049, 8,835,474, RE44,872
Celgene Corp. v. Dr. Reddy’s Labs., Ltd., 16-7704 (D.N.J.) Oct. 20, 2016 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules) 7,465,800, 7,855,217, 7,968,569, 8,530,498, 8,648,095, 9,101,621, 9,101,622
Astellas Pharma Inc. v. Apotex Inc., 16-0976 (D. Del.) Oct. 21, 2016 Hon. Sue L. Robinson Myrbetriq® (mirabegron extended-release tablets) 7,342,117, 7,982,049, 8,835,474, RE44,872
Otsuka Pharm. Co., Ltd. v. Zydus Pharms. USA Inc., 16-7705 (D.N.J.) Oct. 21, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302
Adapt Pharma Operations Ltd. v. Teva Pharms. USA, Inc., 16-7721 (D.N.J.) Oct. 21, 2016 Hon. Jose L. Linares Narcan® (naloxone hydrochloride nasal spray) 9,211,253
Takeda Pharms. U.S.A., Inc. v. Mylan Pharms. Inc., 16-0987 (D. Del.) Oct. 24, 2016 Hon. Sue L. Robinson Colcrys® (colchicine tablets) 7,906,519, 7,935,731, 8,093,298, 7,964,648, 8,093,297, 7,619,004, 7,601,758, 7,820,681, 7,915,269, 7,964,647, 7,981,938, 8,093,296, 8,097,655, 8,415,395, 8,415,396, 8,440,721, 8,440,722
Onyx Therapeutics, Inc. v. Cipla Ltd., 16-0988 (D. Del.) Oct. 24, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042, 7,232,818, 7,491,704, 7,737,112, 8,129,346, 8,207,125, 8,207,126, 8,207,127, 8,207,297
Takeda Pharms. U.S.A., Inc. v. Mylan Pharms. Inc., 16-0202 (N.D.W.V.) Oct. 25, 2016 Hon. Irene M. Keeley Colcrys® (colchicine tablets) 7,906,519, 7,935,731, 8,093,298, 7,964,648, 8,093,297, 7,619,004, 7,601,758, 7,820,681, 7,915,269, 7,964,647, 7,981,938, 8,093,296, 8,097,655, 8,415,395, 8,415,396, 8,440,721, 8,440,722
Millennium Pharms., Inc. v. Hospira, Inc., 16-0998 (D. Del.) Oct. 26, 2016 Hon. Gregory M. Sleet Velcade® (bortezomib for injection) 6,713,446
Onyx Therapeutics, Inc. v. MSN Pharms., Inc., 16-0999 (D. Del.) Oct. 26, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,737,112
Onyx Therapeutics, Inc. v. Sagent Pharms., Inc., 16-1000 (D. Del.) Oct. 26, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042, 7,232,818, 7,491,704, 7,737,112, 8,129,346, 8,207,125, 8,207,126, 8,207,127, 8,207,297
Eli Lilly and Co. v. Cipla Ltd., 16-2911 (S.D. Ind.) Oct. 26, 2016 Hon. Richard L. Young Axiron® (testosterone metered transdermal solution) 8,435,944, 8,993,520, 9,180,194
Onyx Therapeutics, Inc. v. Breckenridge Pharm., Inc., 16-1001 (D. Del.) Oct. 27, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042, 7,232,818, 7,491,704, 7,737,112, 8,129,346, 8,207,125, 8,207,126, 8,207,127, 8,207,297
Galderma Labs., L.P. v. Sun Pharm. Indus. Ltd., 16-1003 (D. Del.) Oct. 27, 2016 Hon. Leonard P. Stark Oracea® (doxycycline tablets) 7,211,267, 7,232,572, 8,603,506, 7,749,532, 8,206,740, 8,394,405, 8,394,406, 8,470,364, 8,709,478, 9,241,946
Eli Lilly and Co. v. Cipla Ltd., 16-1005 (D. Del.) Oct. 28, 2016 Hon. Sue L. Robinson Axiron® (testosterone metered transdermal solution) 8,435,944, 8,993,520, 9,180,194
Eli Lilly and Co. v. Accord Healthcare, Inc., 16-1352 (E.D. Va.) Oct. 28, 2016 Hon. Anthony J. Trenga Cialis® (tadalafil tablets) 6,943,166
Indivior Inc. v. Actavis Labs. UT, Inc., 16-1009 (D. Del.) Oct. 31, 2016 Hon. Richard G. Andrews Suboxone® (buprenorphine / naloxone sublingual film) 8,475,832, 8,017,150, 8,603,514
Otsuka Pharm. Co., Ltd. v. Indoco Remedies Ltd., 16-8085 (D.N.J.) Oct. 31, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302, 9,387,182
Amarin Pharma, Inc. v. Roxane Labs., Inc., 16-2525 (D. Nev.) Oct. 31, 2016 Hon. Miranda M. Du Vascepa® (icosapent ethyl capsules) 8,293,728, 8,318,715, 8,357,677, 8,367,652, 8,377,920, 8,399,446, 8,415,335, 8,426,399, 8,431,560, 8,440,650, 8,518,929, 8,524,698, 8,546,372, 8,617,594
Onyx Therapeutics, Inc. v. Dr. Reddy’s Labs., Inc., 16-1011 (D. Del.) Nov. 1, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,737,112
Onyx Therapeutics, Inc. v. Fresenius Kabi USA, LLC, 16-1012 (D. Del.) Nov. 1, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042, 7,232,818, 7,491,704, 7,737,112, 8,129,346, 8,207,125, 8,207,126, 8,207,127, 8,207,297
Onyx Therapeutics, Inc. v. Qilu Pharma, Inc., 16-1013 (D. Del.) Nov. 1, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,737,112
Eli Lilly and Co. v. Fresenius Kabi USA, LLC, 16-2960 (S.D. Ind.) Nov. 1, 2016 Hon. Tanya Walton Pratt Alimta® (pemetrexed disodium for injection) 7,772,209
Acrux DDS Pty Ltd. v. Kaken Pharm. Co., Ltd., IPR2017-00190 (PTAB) Nov. 2, 2016 N/A Jublia® (efinaconazole topical solution) 7,214,506
Mylan Pharms. Inc. v. Yeda Research & Development Co., Ltd., IPR2017-00195 (PTAB) Nov. 2, 2016 N/A Copaxone® (glatiramer acetate injection) 9,155,776
UCB, Inc. v. Zydus Worldwide DMCC, 16-1023 (D. Del.) Nov. 3, 2016 Hon. Sue L. Robinson Neupro® (rotigotine transdermal system) 8,246,979, 8,246,980, 8,617,591, 6,884,434
Medicis Pharm. Corp. v. Dr. Reddy’s Labs., Ltd., 16-8282 (D.N.J.) Nov. 4, 2016 Hon. Brian R. Martinotti Solodyn® (minocycline hydrochloride extended-release tablets) 5,908,838, 7,790,705, 7,919,483, 8,252,776, 8,268,804, 8,722,650
Otsuka Pharm. Co., Ltd. v. Zhejiang Huahai Pharm. Co., Ltd., 16-8284 (D.N.J.) Nov. 4, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302, 9,387,182
Amarin Pharma, Inc. v. Dr. Reddy’s Labs., Inc., 16-2562 (D. Nev.) Nov. 4, 2016 Hon. Robert C. Jones Vascepa® (icosapent ethyl capsules) 8,293,728, 8,318,715, 8,357,677, 8,367,652, 8,377,920, 8,399,446, 8,415,335, 8,426,399, 8,431,560, 8,440,650, 8,518,929, 8,524,698, 8,546,372, 8,617,594
Mylan Technologies, Inc. v. Monosol Rx, LLC, IPR2017-00200 (PTAB) Nov. 4, 2016 N/A Suboxone® (buprenorphine / naloxone sublingual film) 8,603,514
Mylan Pharms. Inc. v. Qualicaps Co.Ltd, IPR2017-00203 (PTAB) Nov. 4, 2016 N/A Delzicol® (mesalamine delayed-release capsule) 6,649,180
Onyx Therapeutics, Inc. v. InnoPharma, Inc., 16-1036 (D. Del.) Nov. 8, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042, 7,737,112, 8,207,297
Onyx Therapeutics, Inc. v. Apotex Inc., 16-1039 (D. Del.) Nov. 8, 2016 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,737,112
Forest Labs., LLC v. Apotex Corp., 16-1045 (D. Del.) Nov. 10, 2016 Hon. Leonard P. Stark Namzaric® (memantine hydrochloride / donepezil hydrochloride extended-release capsules) 8,039,009, 8,058,291, 8,338,485, 8,338,486, 8,580,858
Alcon Research, Ltd. v. Akorn, Inc., 16-3092 (S.D. Ind.) Nov. 11, 2016 Hon. Jane Magnus-Stinson Pataday® (olopatadine hydrochloride ophthalmic solution) 6,995,186, 7,402,609
The Medicines Co. v. Akorn, Inc., 16-8546 (D.N.J.) Nov. 15, 2016 Hon. Peter G. Sheridan Angiomax® (bivaluirudin for injection) 7,582,727, 7,598,343
United Therapeutics Corp. v. Par Sterile Products, LLC, 16-8548 (D.N.J.) Nov. 16, 2016 Hon. Peter G. Sheridan Remodulin® (treprostinil sodium for injection) 8,497,393, 9,199,908, 7,999,007, 8,653,137, 8,658,694
United Therapeutics Corp. v. Par Sterile Products, LLC, 16-1066 (D. Del.) Nov. 17, 2016 Hon. Sue L. Robinson Remodulin® (treprostinil sodium for injection) 8,497,393, 9,199,908, 7,999,007, 8,653,137, 8,658,694
Apotex Inc. v. Alcon Research, Ltd., 16-3145 (S.D. Ind.) Nov. 17, 2016 Hon. William T. Lawrence Pataday® (olopatadine hydrochloride ophthalmic solution) 6,995,186, 7,402,609
Alkermes Pharma Ireland Ltd. v. Otsuka Pharm. Co., Ltd., IPR2017-00287 (PTAB) Nov. 17, 2016 N/A Abilify® (aripiprazole tablets) 9,125,939
Aptalis Pharma Canada ULC v. Par Pharm., Inc., 16-1069 (D. Del.) Nov. 18, 2016 Hon. Sue L. Robinson Pylera® (bismuth subcitrate potassium / metronidazole / tetracycline hydrochloride capsules) 6,350,468
Amarin Pharma, Inc. v. Teva Pharms. USA, Inc., 16-2658 (D. Nev.) Nov. 18, 2016 Hon. Miranda M. Du Vascepa® (icosapent ethyl capsules) 8,293,728, 8,318,715, 8,357,677, 8,367,652, 8,377,920, 8,399,446, 8,415,335, 8,426,399, 8,431,560, 8,440,650, 8,518,929, 8,524,698, 8,546,372, 8,617,594
Mylan Pharms. Inc. v. Icos Corp., IPR2017-00323 (PTAB) Nov. 22, 2016 N/A Cialis® (tadalafil tablets) 6,943,166
Merck, Sharp & Dohme Corp. v. Strides Pharma Inc., 16-8850 (D.N.J.) Nov. 29, 2016 Hon. Brian R. Martinotti Sustiva® (efavirenz tablets) 6,639,071, 6,939,964, 6,673,372
Forest Labs., LLC v. Teva Pharms. USA, Inc., 16-1114 (D. Del.) Nov. 30, 2016 Hon. Richard G. Andrews Linzess® (linaclotide capsules) 7,304,036, 7,371,727, 7,704,947, 7,745,409, 8,080,526, 8,110,553, 8,748,573, 8,802,628, 8,933,030
Eli Lilly and Co. v. Apotex, Inc., 16-0941 (E.D. Va.) Nov. 30, 2016 Hon. M. Hannah Lauck Cialis® (tadalafil tablets) 6,943,166
Mallinckrodt IP v. Mylan Labs. Ltd., 16-1115 (D. Del.) Dec. 1, 2016 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 6,028,222, 6,992,218
Malinckrodt IP v. Innopharma Licensing LLC, 16-1116 (D. Del.) Dec. 1, 2016 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 9,399,012
Astellas Pharma Inc. v. Actavis Labs. FL, Inc., 16-1120 (D. Del.) Dec. 2, 2016 Hon. Gregory M. Sleet Xtandi® (enzalutamide capsules) 7,709,517, 8,183,274, 9,126,941
Merck, Sharp & Dohme Corp. v. Aurobindo Pharma Ltd., 16-9033 (D.N.J.) Dec. 6, 2016 Hon. Brian R. Martinotti Sustiva® (efavirenz tablets) 6,639,071, 6,939,964, 6,673,372
Horizon Pharma, Inc. v. Dr. Reddy’s Labs. Inc., 16-9035 (D.N.J.) Dec. 6, 2016 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) 9,393,208
Valeant Pharms. Int’l, Inc. v. Actavis Labs. FL, Inc., 16-9038 (D.N.J.) Dec. 6, 2016 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide tablets) 8,420,663, 8,524,276, 8,956,651, 9,180,125, 9,314,461
MonoSol Rx, LLC v. Icos Corp., IPR2017-00412 (PTAB) Dec. 6, 2016 N/A Cialis® (tadalafil tablets) 6,943,166
Orexo AB v. Actavis Elizabeth LLC, 16-1138 (D. Del.) Dec. 7, 2016 Hon. Sue L. Robinson Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride dihydrate sublingual tablets) 9,439,900
Orexo AB v. Actavis Elizabeth LLC, 16-1139 (D. Del.) Dec. 7, 2016 Hon. Sue L. Robinson Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride dihydrate sublingual tablets) 9,439,900
Abraxis Bioscience, LLC v. Cipla Ltd., 16-9074 (D.N.J.) Dec. 7, 2016 Hon. John Michael Vazquez Abraxane® (paclitaxel protein-bound particles for injectable suspension) 7,820,788, 7,923,536, 8,138,229, 8,853,260
Astellas Pharma Inc. v. Apotex Inc., 16-1166 (D. Del.) Dec. 9, 2016 Hon. Gregory M. Sleet Xtandi® (enzalutamide capsules) 7,709,517, 8,183,274, 9,126,941
Astellas Pharma Inc. v. Zydus Pharms. (USA) Inc., 16-1167 (D. Del.) Dec. 9, 2016 Hon. Gregory M. Sleet Xtandi® (enzalutamide capsules) 7,709,517, 8,183,274, 9,126,941
Apicore US LLC v. Pfizer Inc., 16-1174 (D. Del.) Dec. 12, 2016 Hon. Sue L. Robinson Tikosyn® (dofetilide capsules) 6,124,363
Eli Lilly and Co. v. Ajanta Pharma, Ltd., 16-0714 (E.D. Va.) Dec. 13, 2016 Hon. Mark S. Davis Cialis® (tadalafil tablets) 6,943,166
Bayer Healthcare LLC v. Teva Pharms. USA, Inc., 16-1220 (D. Del.) Dec. 16, 2016 Hon. Leonard P. Stark Nexavar (sorafenib tosylate tablets) 8,877,933
Bayer Healthcare LLC v. Teva Pharms. USA, Inc., 16-1221 (D. Del.) Dec. 16, 2016 Hon. Leonard P. Stark Stivarga® (regorafenib tablets) 7,351,834, 8,637,553, 8,680,124, 9,458,107
Bayer Healthcare LLC v. Apotex, Inc., 16-1222 (D. Del.) Dec. 16, 2016 Hon. Leonard P. Stark Stivarga® (regorafenib tablets) 8,637,553
Millennium Pharms., Inc. v. MSN Labs. Private Ltd., 16-1255 (D. Del.) Dec. 19, 2016 Hon. Gregory M. Sleet Velcade® (bortezomib for injection) 6,713,446, 6,958,319
Teva Pharms. USA, Inc. v. Dr. Reddy’s Labs., Ltd., 16-1267 (D. Del.) Dec. 19, 2016 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate injection) 9,402,874
Impax Labs., Inc. v. Actavis Labs. FL, Inc., 16-9416 (D.N.J.) Dec. 20, 2016 Hon. Stanley R. Chesler Rytary® (levodopa / carbidopa extended-release capsules) 9,463,246
Eli Lilly and Co. v. Hospira, Inc., 16-3460 (S.D. Ind.) Dec. 21, 2016 Hon. Sarah Evans Barker Alimta® (pemetrexed disodium for injection) 7,772,209
Sanofi-Aventis U.S. LLC v. Watson Labs., Inc., 16-1298 (D. Del.) Dec. 22, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Sanofi-Aventis U.S. LLC v. Aurobindo Pharma USA, Inc., 16-1299 (D. Del.) Dec. 22, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Sanofi-Aventis U.S. LLC v. Alvogen Pine Brook LLC, 16-1300 (D. Del.) Dec. 22, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Biodelivery Sciences Int’l, Inc. v. Teva Pharms. USA, Inc., 16-1303 (D. Del.) Dec. 22, 2016 Hon. Gregory M. Sleet Belbuca® (buprenorphine buccal film) 7,579,019, 8,147,866
Allergan, Inc. v. Deva Holding A.S., 16-1447 (E.D. Tex.) Dec. 22, 2016 Hon. Robert W. Schroeder, III Restasis® (cyclosporine ophthalmic emulsion) 8,629,111, 8,633,162, 8,642,556, 8,648,048, 8,685,930, 9,248,191
Wyeth LLC v. Alembic Pharms., Ltd., 16-1305 (D. Del.) Dec. 23, 2016 Hon. Richard G. Andrews Bosulif® (bosutinib tablets) 7,417,148, 7,767,678
Rhodes Pharms. L.P. v. Indivior Inc., 16-1308 (D. Del.) Dec. 23, 2016 Hon. Sue L. Robinson Suboxone® (buprenorphine / naloxone sublingual film) 9,370,512
Sanofi-Aventis U.S. LLC v. Accord Healthcare, Inc., 16-1311 (D. Del.) Dec. 27, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Sanofi-Aventis U.S. LLC v. Apotex, Inc., 16-1312 (D. Del.) Dec. 27, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Sanofi-Aventis U.S. LLC v. Alembic Pharms. Ltd., 16-1316 (D. Del.) Dec. 28, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Sanofi-Aventis U.S. LLC v. Glenmark Pharms. Inc., USA, 16-1326 (D. Del.) Dec. 29, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
AstraZeneca AB v. Cipla Ltd., 16-9583 (D.N.J.) Dec. 29, 2016 Hon. Mary L. Cooper Nexium® 24HR (esomeprazole magnesium delayed-release capsules) 6,369,085, 7,411,070
Sanofi-Aventis U.S. LLC v. Emcure Pharms. Ltd., 16-1330 (D. Del.) Dec. 30, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 9,186,346
Sanofi-Aventis U.S. LLC v. Torrent Pharma Inc., 16-1333 (D. Del.) Dec. 30, 2016 Hon. Gregory M. Sleet Aubagio® (teriflunomide tablets) 6,794,410, 9,186,346
Otsuka Pharm. Co., Ltd. v. Orchid Pharma Ltd., 16-9603 (D.N.J.) Dec. 30, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,358,207
Back to Top